Immunological look at the treatment of coronavirus COVID-19 and SARS-2 infections
Open Access
- 30 March 2020
- journal article
- Published by LLC Information and Research Center Likarska Sprava in Likars'ka Sprava
- No. 1-2,p. 3-7
- https://doi.org/10.31640/jvd.1-2.2020(1)
Abstract
The article outlines the causes of deaths when using a combination of azithromycin with Plaquenil®. Immunological substantiation of the main factors leading to vascular and pulmonary pathology (triggering angiotensin-converting enzyme and helper aggression in the lungs) is given. An immunotherapy method that eliminates the etiological links of the processes occurring during COVID-19 viremia is proposed. The method of prophylaxis of personnel in contact with patients is to use specific antibodies to coronaviruses found in immunoglobulin with intramuscular injection. A treatment schema for severe patients with COVID-19, SARS-2 is proposed.Keywords
This publication has 1 reference indexed in Scilit:
- History of investigation and current classification of coronaviruses (Nidovirales: Coronaviridae)Russian Journal of Infection and Immunity, 2020